NDC 81033-035-04 - TOPIRAMATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81033-035
- Requested NDC
- 81033-035-04
- Package NDCs from labels
- 81033-035-04, 81033-035-14, 81033-035-06, 81033-035-15, 81033-035-08, 81033-035-16
- Manufacturer
- Kesin Pharma
- Effective date
- 2026-06-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| TOPIRAMATE - Kesin Pharma | Kesin Pharma | 2026-06-16 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| topiramate | TOPIRAMATE | Proficient Rx LP | 80481455-7ad7-4f44-8113-b8b61d8581a0 | 2022-11-01 | Warnings, Adverse reactions | 0H73WJJ391 |
| TOPIRAMATE | TOPIRAMATE | Proficient Rx LP | a30c583a-4b0a-43a6-ae76-19b1a5e916ca | 2022-10-01 | Warnings, Adverse reactions | 0H73WJJ391 |
| REFRESH OPTIVE | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 7f8d88af-fd3b-4138-af61-f24c59ccebd7 | 2022-09-23 | Warnings | PDC6A3C0OX |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | ebd0839e-2e1d-4e0e-986c-19f1f5c76358 | 2022-09-19 | Warnings | PDC6A3C0OX |
| Topiramate | TOPIRAMATE | Asclemed USA, Inc. | 4e476c33-3590-4c6f-981d-915623cdacf0 | 2022-09-09 | Warnings, Adverse reactions | 0H73WJJ391 |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | PDC6A3C0OX |
| Glycerinum | GLYCERINUM | Hahnemann Laboratories, INC. | e34f8796-85b5-2946-e053-2995a90a251e | 2022-07-08 | PDC6A3C0OX | |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | PDC6A3C0OX |
| Topiramate | TOPIRAMATE | Proficient Rx LP | e382a731-ef73-4990-bc74-ffc3a91ff3ba | 2022-06-01 | Warnings, Adverse reactions | 0H73WJJ391 |
| Topiramate | TOPIRAMATE | Proficient Rx LP | 57ac12ed-27f0-4f5c-96ae-a7433714b429 | 2022-05-02 | Warnings, Adverse reactions | 0H73WJJ391 |
| Miracle FootCream Lavender | UREA, GLYCERIN, ALOE, DISODIUM EDTA | Aloe Vera Korea Co.,Ltd. | db520c80-2a2a-5eb1-e053-2995a90a5bb4 | 2022-03-28 | Warnings | PDC6A3C0OX |
| Miracle FootCream Lemon | UREA, GLYCERIN, ALOE, DISODIUM EDTA | Aloe Vera Korea Co.,Ltd. | db525c63-29fd-2033-e053-2995a90a56b9 | 2022-03-28 | Warnings | PDC6A3C0OX |
| Topiramate | TOPIRAMATE | Aphena Pharma Solutions - Tennessee, LLC | 3b18b43c-0de2-4acf-b0d5-f1b601d496de | 2021-05-03 | Warnings, Adverse reactions | 0H73WJJ391 |
| Topiramate | TOPIRAMATE | Proficient Rx LP | e9c4e279-0ef9-4e96-8741-dfe7556953d9 | 2021-01-01 | Warnings, Adverse reactions | 0H73WJJ391 |
| Topiramate | TOPIRAMATE | Proficient Rx LP | a712d050-d5de-4685-a80a-548ab080fdb7 | 2021-01-01 | Warnings, Adverse reactions | 0H73WJJ391 |
| Topiramate | TOPIRAMATE | Proficient Rx LP | 5d9b2c1d-565e-4c43-96ef-e5cd2593d0a8 | 2020-09-01 | Warnings, Adverse reactions | 0H73WJJ391 |
| topiramate | TOPIRAMATE | Proficient Rx LP | cc918c0d-2b1e-4fa0-b4d3-9dbc28718018 | 2020-02-01 | Warnings, Adverse reactions | 0H73WJJ391 |
| topiramate | TOPIRAMATE | Proficient Rx LP | 584e16c5-5ffb-4bfc-ba80-4340afd25e8e | 2020-01-01 | Warnings, Adverse reactions | 0H73WJJ391 |
| Topiramate | TOPIRAMATE | Proficient Rx LP | 7d6752ce-7a56-4b04-ab15-cbd40aa5cc94 | 2019-11-01 | Warnings, Adverse reactions | 0H73WJJ391 |
| Topiramate | TOPIRAMATE | Proficient Rx LP | efc0d85e-fddc-4122-85b2-da2d2cb2f9d8 | 2019-11-01 | Warnings, Adverse reactions | 0H73WJJ391 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.